Gujarat Alkalies & Chemicals schedules board meeting to approve Q1 2026 provisional results
The board will meet on 23 July 2026 to consider and approve the standalone and consolidated un‑audited financial results for the quarter ended 30 June 2026, in compliance with SEBI LODR regulations.
What Gujarat Alkalies & Chemicals announced
Gujarat Alkalies and Chemicals Ltd (GACL) informed the Bombay Stock Exchange that its Board of Directors will meet on 23 July 2026. The primary purpose of the meeting is to consider and approve the standalone and consolidated un‑audited (provisional) financial results for the first quarter ended 30 June 2026. The notice was filed on 13 July 2026 and references compliance with Regulation 29(1)(a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Board meeting details
- Date of meeting: Thursday, 23 July 2026
- Time & venue: Not disclosed in the filing; standard practice is to hold the meeting at the company’s registered office.
- Agenda items: Approval of Q1 FY2026 provisional results (both standalone and consolidated), along with any other business that may arise.
- Regulatory compliance: The notice explicitly cites Regulation 29(1)(a) of SEBI (LODR) Regulations, which mandates that listed entities disclose the date of board meetings where financial results are to be considered.
Regulatory compliance
The filing underscores GACL’s adherence to SEBI’s disclosure framework. Regulation 29(1)(a) requires listed companies to intimate the date of board meetings where financial statements are to be considered, ensuring transparency for shareholders and market participants. By filing this intimation, GACL fulfills its statutory obligation and provides investors with a clear timeline for when the provisional results will be examined.
Key facts at a glance
| Detail | Value |
|---|---|
| Company | Gujarat Alkalies & Chemicals Ltd |
| BSE Scrip Code | 530001 |
| Board meeting date | 23 July 2026 |
| Filing date | 13 July 2026 (08:24:15 UTC) |
| Agenda | Approval of standalone & consolidated un‑audited Q1 FY2026 results |
| Regulatory reference | SEBI (LODR) Reg. 29(1)(a) |
| Source | BSE filing (PDF) |
Why this matters for investors
The announcement signals that GACL will soon disclose its Q1 FY2026 financial performance, albeit in a provisional, unaudited form. Investors typically await such results to gauge the company’s operational health, revenue trends, and profitability for the quarter. While the filing does not reveal any numbers, the scheduled board approval date gives shareholders a clear expectation of when the results will become publicly available. Moreover, compliance with SEBI regulations reassures investors that the company follows required disclosure norms, reducing regulatory risk.
Conclusion
Gujarat Alkalies & Chemicals has formally announced a board meeting on 23 July 2026 to approve its Q1 FY2026 provisional financial results. The filing satisfies SEBI’s disclosure requirements, but no financial details were disclosed in the intimation. Investors should monitor subsequent releases for the actual results, which will provide insight into the company’s quarterly performance.
Frequently asked questions
Related stocks
Source filing: view original